Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polis

Showing results (581-590 of 614) with videos related to

Pageof 62
Sort By:
Annals of Internal Medicine|July 3, 2002
High prevalence of osteonecrosis of the femoral head in HIV-infected adultsKirk D Miller, Henry Masur, Elizabeth C Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2000
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patientsR A Lempicki, J A Kovacs, M W Baseler, et al.
Clinical Immunology (Orlando, Fla.)|April 19, 2015
Tuberculosis specific responses following therapy for TB: Impact of HIV co-infectionS Siddiqui, Y Sarro, B Diarra, et al.
Current HIV Research|June 24, 2022
SARS-CoV-2/COVID-19: Clinical Course Among Subjects HIV-1-Infected in Sao PauloMariana A Monteiro, Gabriela S Prates, Najara A de Lima Nascimento, et al.
Cell Metabolism|August 27, 2024
Serine and glycine physiology reversibly modulate retinal and peripheral nerve functionEsther W Lim, Regis J Fallon, Caleb Bates, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2015
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver DiseaseSarah Kattakuzhy, Eleanor Wilson, Sreetha Sidharthan, et al.
Plos Pathogens|April 7, 2007
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremiaFrank Maldarelli, Sarah Palmer, Martin S King, et al.
Nature Medicine|July 14, 1998
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adultsR E Walker, C S Carter, L Muul, et al.
Archives of Internal Medicine|May 20, 1998
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USAR J Whitley, M A Jacobson, D N Friedberg, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1996
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patientsR T Davey, D G Chaitt, G F Reed, et al.
Pageof 62

Showing results (581-590 of 614) with videos related to

Sort By:
Pageof 62
Annals of Internal Medicine|July 3, 2002
High prevalence of osteonecrosis of the femoral head in HIV-infected adultsKirk D Miller, Henry Masur, Elizabeth C Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2000
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patientsR A Lempicki, J A Kovacs, M W Baseler, et al.
Clinical Immunology (Orlando, Fla.)|April 19, 2015
Tuberculosis specific responses following therapy for TB: Impact of HIV co-infectionS Siddiqui, Y Sarro, B Diarra, et al.
Current HIV Research|June 24, 2022
SARS-CoV-2/COVID-19: Clinical Course Among Subjects HIV-1-Infected in Sao PauloMariana A Monteiro, Gabriela S Prates, Najara A de Lima Nascimento, et al.
Cell Metabolism|August 27, 2024
Serine and glycine physiology reversibly modulate retinal and peripheral nerve functionEsther W Lim, Regis J Fallon, Caleb Bates, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2015
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver DiseaseSarah Kattakuzhy, Eleanor Wilson, Sreetha Sidharthan, et al.
Plos Pathogens|April 7, 2007
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremiaFrank Maldarelli, Sarah Palmer, Martin S King, et al.
Nature Medicine|July 14, 1998
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adultsR E Walker, C S Carter, L Muul, et al.
Archives of Internal Medicine|May 20, 1998
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USAR J Whitley, M A Jacobson, D N Friedberg, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1996
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patientsR T Davey, D G Chaitt, G F Reed, et al.
Pageof 62